Insights On Outsourced Drug Development

  1. Validating Antibodies With Knock-Out Technologies 10/8/2024

    Watch to learn about how one company achieves antibody validation through knock-out (KO) technologies as well as the significance of gene KO technologies in the large-scale screening of antibodies.

  2. Accelerating mRNA Therapy Production With Digital Innovation 10/21/2025

    Scaling mRNA therapies requires more than innovation—it demands precision. Discover how digital tools like automation and analytics are helping life science companies streamline production.

  3. Accelerating Development With Rapid Delivery Of Toxicological Study Material 3/19/2025

    Explore key strategies and technologies designed to address the analytical considerations and material flows to facilitate the rapid delivery of toxicological material.

  4. Tablet Manufacturing Technologies For Solid Drug Formulation 4/2/2025

    Compressed tablets are common oral solid dosages that contain the API and various excipients. Learn about the critical steps in selecting manufacturing methods and excipients to achieve the desired therapeutic effects and stability.

  5. Development Of Separation Methods for GLP-1 Synthetic Peptides 6/27/2025

    Peptides offer precise, low-cost therapeutic potential, especially in GLP-1 drugs for diabetes and weight loss. A new HPLC-UV/MS method ensures consistent quality and analysis of these compounds.

  6. How Isogenic Organ-Chips Are Transforming The Future Of Research 6/25/2026

    Modeling the human brain requires more than simplified systems. New approaches that incorporate diverse cell types are improving how researchers study neurovascular function with greater precision.

  7. New Approaches To Tailored Release Profiles 7/7/2025

    Tailored drug release is evolving from formulation tactic to precision therapy strategy, optimizing timing, site, and rate of delivery for improved patient outcomes.

  8. The Complete Guide To Immunohistochemistry 9/24/2024

    Immunohistochemistry (IHC) is a tool for visualizing the distribution and localization of antigens within tissue sections. Learn about IHC sample preparation, detection and amplification systems, and more.

  9. The Role Of CDMOs In Supporting Generic Drug Development 7/15/2025

    Bringing complex generics to market requires deep expertise. Learn how a CDMO can help navigate regulatory, technical, and commercial challenges with end-to-end development and manufacturing support.

  10. A Study To Assess Organoid Size And Cell Count From 3D Image Analysis 4/4/2025

    Recent advancements in 3D patient-derived organoids (PDOs) offer improved predictive power over traditional 2D assays. Explore a patented bioprocess for PDO expansion that could revolutionize drug discovery, especially in oncology.